Margaron; Philippe Maria Clotaire
Patent Applications and Registrations
Patent applications and USPTO patent grants for Margaron; Philippe Maria Clotaire.The latest application filed is for "sustained delivery formulations of rapamycin compounds".
- Margaron; Philippe Maria Clotaire - Vancouver CA
- Margaron; Philippe Maria Clotaire - Burnaby CA
| Patent | Date |
|---|---|
| Sustained delivery formulations of rapamycin compounds Grant 8,313,763 - Margaron , et al. November 20, 2 | 2012-11-20 |
| Method for reducing or preventing PDT related inflammation Grant 8,106,038 - Margaron , et al. January 31, 2 | 2012-01-31 |
| Sustained delivery formulations of rapamycin compounds App 20070280992 - Margaron; Philippe Maria Clotaire ; et al. | 2007-12-06 |
| Use of low-dose PDT to inhibit restenosis Grant 7,122,568 - Allison , et al. October 17, 2 | 2006-10-17 |
| Selective treatment of endothelial somatostatin receptors App 20060089299 - Hsiang; York ; et al. | 2006-04-27 |
| Use of PDT to inhibit intimal hyperplasia App 20040208855 - Allison, Beth Anne ; et al. | 2004-10-21 |
| Method to prevent xenograft transplant rejection Grant 6,659,107 - Obochi , et al. December 9, 2 | 2003-12-09 |
| Use of PDT to inhibit intimal hyperplasia Grant 6,609,014 - Allison , et al. August 19, 2 | 2003-08-19 |
| Method for reducing or preventing PDT related inflammation App 20030083649 - Margaron, Philippe Maria Clotaire ; et al. | 2003-05-01 |
| Method to prevent xenograft transplant App 20020139938 - Obochi, Modestus O.K. ; et al. | 2002-10-03 |
| Selective treatment of endothelial somatostatin receptors App 20020137676 - Hsiang, York ; et al. | 2002-09-26 |
| Method to prevent xenograft transplant rejection Grant 6,364,907 - Obochi , et al. April 2, 2 | 2002-04-02 |
| Methods to treat arterial plaque Grant 6,235,767 - Kelly , et al. May 22, 2 | 2001-05-22 |
| Methods to treat arterial plaque Grant 5,834,503 - Kelly , et al. November 10, 1 | 1998-11-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 